Contribution of annexin A1 to anticancer immunosurveillance

Mouse cancers lacking the expression of annexin A1 (ANXA1) fail to respond to immunogenic chemotherapies. This has been initially explained by the requirement of extracellular ANXA1 (which is released from dying cancer cells) to engage formyl peptide receptor-1 (FPR1) on dendritic cells (DC) for the...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncoimmunology
Hlavní autoři: Baracco, Elisa Elena, Stoll, Gautier, Van Endert, Peter, Zitvogel, Laurence, Vacchelli, Erika, Kroemer, Guido
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2019
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7457921/
https://ncbi.nlm.nih.gov/pubmed/32923172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2019.1647760
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky